TrialArthritis & rheumatology (Hoboken, N.J.)2019

The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial.

Paula Dakin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.